Niklas Zojer

Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization

Niklas Zojer, Robert Königsberg, Jutta Ackermann et al. · Blood · 2000 · 322 citations

Medicine, Molecular Biology, Oncology +11

Presence of a p53 Gene Deletion in Patients With Multiple Myeloma Predicts for Short Survival After Conventional-Dose Chemotherapy

Johannes Drach, Jutta Ackermann, E. Fritz et al. · Blood · 1998 · 321 citations

Medicine, Molecular Genetics, Oncology +17

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Meletios Α. Dimopoulos, Francesca Gay, Fredrik Schjesvold et al. · The Lancet · 2018 · 236 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes

Johannes Drach, Andrea Gsur, G Hamilton et al. · Blood · 1996 · 223 citations · Full text

Life Sciences, Immunology, Molecular Biology +11

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Christoph Kornauth, Tea Pemovska, Gregory I. Vladimer et al. · Cancer Discovery · 2021 · 207 citations · Full text

Medicine, Hematology, Oncology +12